The sector will reach $6.27 billion by 2028 at a compound annual growth rate of 9.1%.

DublinAnd January 22, 2023 /PRNewswire/ – File “Global Fruit Market, Size, Global Outlook 2023-2028, Industry Trends, Growth, Inflation Impact, Opportunity Company Analysis” The report has been added to an offer.

Research and Markets logo

Research and Markets logo

It is expected to reach the global viscosity market 6.27 billion US dollars By 2028 according to the publisher. Patients with osteoarthritis have a minimally invasive treatment option called viscosity.

As viscosity increases, hyaluronic acid is pushed into the joints. The synovial fluid that covers the joints contains hyaluronic acid, which is a naturally occurring substance. It lubricates the joints to allow the bones to move freely and reduce discomfort. Hyaluronic acid levels in the joints are lower in people with osteoarthritis, which causes pain.

According to the research results, the viscosity market was all over the world 3.71 billion US dollars in 2022.

The global viscosity market will grow at a CAGR of 9.14% during the forecast period:

Increase in the incidence of osteoporosis, rising geriatric population, and increase in the number of product launches and product approvals are some of the major factors driving the growth in size of the global viscosity supplement market. Arthritis is one of the most common types of arthritis.

In 2019, the Centers for Disease Control and Prevention estimated that 32.5 million Americans (1 in 7 adults) had osteoporosis. Due to the increase in chronic diseases such as obesity, diabetes and heart disease, the prevalence of osteoporosis has reached alarming levels. In addition, lack of physical activity, such as aerobic exercise, increases the need for knee and hip osteoarthritis treatment and drives market expansion.

Single injection viscosity owns the lion’s share

By procedure, the viscosity market is divided into three segments, that is, single injection viscosity injection, three viscosity injection, and five viscosity injection. Among all, the current viscosity supplement market is dominated by single injections. Demand for outpatient surgeries providing same-day surgical care, including preventive (surgical) and diagnostic procedures, is driving the single injection segment. Further, the increase in product launches and focus on developing single injections for the treatment of osteoarthritis is expected to contribute to the significant growth of the single injection market over the forecast period.

By Application: Knee Osteoarthritis segment dominates the market share

Due to the increasing prevalence of knee osteoarthritis and the increasing number of elderly people, who are more susceptible to knee osteoarthritis, the knee osteoarthritis segment has dominated the viscoelastic market and is expected to maintain this trend during the forecast period. In addition, the effect of aging, which reduces the amount of water in the cartilage and reduces its ability to absorb shock and cushion, makes the elderly population more susceptible to knee osteoarthritis.

Orthopedic Clinics / Ambulatory Surgery Centers division is growing at a significant rate of growth

By end users, the Viscosupplementation market is segmented into hospitals and orthopedic clinics/ambulatory surgery centres. Outpatient service locations, particularly those providing ambulatory surgery and office treatments from physicians, have grown to be fierce competitors to hospitals due to the recent adoption of value-based care. Orthopedic clinics/ambulatory surgery centers offer practical and financial benefits, such as quick access to patients, affordable prices, more opportunities for physician involvement, and outpatient facilities. Hence they gain a dominant market share in the viscosity market.

By region: North Amarica And Asia Pacific It owns a large market share

North Amarica It occupies a dominant position in the global viscosity supplement market. Factors contributing to the growth of viscous augmentation in the North American region are the increasing prevalence of osteoporosis and related diseases, older age, an established health care system, and a growing desire for non-surgical procedures. In addition to, Asia Pacific It is expected to grow at a significant growth rate during the forecast period due to the increase in the elderly population and the rise in healthcare expenditures.

Market segmentation


1. One time viscosity injection
2. Three viscosity injections
3. Five viscosity injections


1. Knee osteoarthritis
2. Hip osteoarthritis
3. Fragility of the hand / wrist
4. Ankle/foot osteoarthritis
5. Others

end user

1. Hospitals
2. Orthopedic clinics / ambulatory surgery centers


1. North Amarica
2. Europe
3. Asia Pacific
4. The rest of the world

The main players

1. Anika Therapeutics Inc.
2. Sanofi
3. Zimmer Biomet
4. Smith Onview plc
5. The biomedical life cycle
6. LG Life Sciences Ltd.
7. F.Hoffmann-La Roche Ltd.
8. Chugai Pharmaceutical Co., Ltd.

Main topics covered:

1 Introduction

2. Research and methodology

3. Executive summary

4. Market dynamics

5. Global viscosity market

6. Market Share – Global Viscosity Analysis

7. Product – Global Viscosity Market

8. Application – Global Viscosity Market

9. End User – Global Viscosity Market

10. Region – Global Viscosity Market

11. Company analysis

For more information on this report visit

About is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, major companies, new products and the latest trends.

Media contact:

Research and markets
Laura Woodmentor manager

For EST office hours, call +1-917-300-0470
For US/Canada, call toll-free at +1-800-526-8630
For GMT office hours, call +353-1-416-8900

US fax: 646-607-1907
Fax (outside the US): +353-1-481-1716



View original content: 301727320.html

SOURCE Research and Markets

Leave a Comment